Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $59.38 USD
Change Today -0.72 / -1.20%
Volume 9.0M
As of 8:04 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert M. Davis J.D.

Chief Financial Officer and Executive Vice President, Merck & Co. Inc.
AgeTotal Calculated CompensationThis person is connected to 1 board members in 1 different organizations across 4 different industries.

See Board Relationships
47$12,762,518
As of Fiscal Year 2014

Background*

Mr. Robert M. Davis, also known as Rob, J.D., served as the Chief Financial Officer and Executive Vice President at Merck & Co. Inc. since April 23, 2014. Mr. Davis was an Advisor at HealthQuest Capital. Mr. Davis served as Corporate Vice President at Baxter International Inc. from May 17, 2006 to March 27, 2014 and also served as its President at Medical Products from October 2010 to March 27, 2014. Mr. Davis served as the President at Renal at Baxter International ...

Read Full Background

Corporate Headquarters*

2000 Galloping Hill Road
Kenilworth, New Jersey 07033

United States

Phone: 908-740-4000
Fax: --

Board Members Memberships*

Former Trustee
Director

Education*

Bachelor's Degree
Miami University
JD
Northwestern University School of Law
MBA
J.L. Kellogg School of Management, Northwestern University

Other Affiliations*

Annual Compensation*

Salary$650,384
Bonus$2,500,000
Total Annual Compensation$3,150,384

Stock Options*

Restricted Stock Awards$7,294,765
All Other Compensation$306,213
Unexercisable Options192,572
Total Number of Options192,572

Total Compensation*

Total Annual Cash Compensation$4,268,847
Total Short Term Compensation$3,150,384
Other Long Term Compensation$7,600,978
Total Calculated Compensation$12,762,518
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MRK:US $59.38 USD -0.72

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.0M GBP
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
$1.4M
Jean-Paul Agon Chairman, Chief Executive Officer and Chairman of Strategy & Sustainable Development Committee
L'Oreal SA
€4.0M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK & CO. INC., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.